Skip to search formSkip to main contentSkip to account menu

Anrukinzumab

Known as: IMA-638, Immunoglobulin G1, anti-(human interleukin-13) Humanized Mouse Monoclonal Gamma 1 Heavy Chain 235L>A, 238G>A (221-218')-disulfide with Humanized Mouse Monoclonal Kappa Light Chain (227-227'':230-230'')-bisdisulfide Dimer 
A humanized monoclonal antibody directed against interleukin-13 (IL-13) with anti-asthmatic and anti-inflammatory activities. Anrukinzumab binds to… 
National Institutes of Health

Related topics

Related topics

1 relation
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
IMA-638 in Active Ulcerative Colitis: Efficacy and Safety from a Phase IIa Multicenter Study: 1751
2013
2013
IMA-638 in Active Ulcerative Colitis from a Phase IIa Multicenter Study: Correlation between Fecal Calprotectin Levels and Clinical Activity: 1753
2012
2012
Moving from an asthma pipe dream to a pipeline
After decades of stubbornly slow progress in asthma drug development, recent results from a trial of GlaxoSmithKline's… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)